US FDA enforcement: an analysis of the warning letters issued in 2024

In 2024, one of the top enforcement priorities for the US Food and Drug Administration (FDA) remained the removal of unauthorised tobacco products from the market, with a particular focus on e-cigarettes. These products received significantly more warning letters than any other tobacco category. Since 2020, the agency has emphasised enforcement against unauthorised e-cigarettes, as outlined in its industry guidance, and this approach has continued into 2024.

This report examines the US Food and Drug Administration (FDA) enforcement measures taken in relation to unauthorised tobacco products, and analyses the warning letters sent out throughout 2024.

Free sample
I'm already a subscriber

Kristina Iashina

Junior legal analyst
Kristina holds a Masters Degree in International Law from Moscow State Linguistic University, Russia. In 2020 she completed a six-month exchange programme at the University of Malaga. She has worked as a legal secretary at the Ninth Arbitration Court of Appeal, Russia; and as a legal assistant in a law firm in Moscow.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation